EmailStory Stocks®
Archive
Last Update: 04-Apr-13 11:18 ET
S&P Consumer Discretionary Index 0.34%, in-line with the broader market
The consumer discretionary group is in-line with the broader market in early trade. The retail group is also in the green with the Retail HOLDRS Trust (RTH) 1.1% and the SPDR S&P Retail ETF (XRT) 0.4%. Trading higher following earnings/guidance: BSET +2.6%, LULU +1.7%... Trading lower following earnings/guidance: ISCA -1.5%, RAD -1.2% Other notable mentions: DIS (plans to shutdown LucasArts games studio, according to reports)
Leaders: SKT 0.6% (increases quarterly dividend by 7.1% to $0.225 per share from $0.21 per share), CVS 1.7% (CVS Caremark to pay $11 mln in drug-record settlement, according to reports), CROX 0.8% (Crocs named Andy Sackmann as chief marketing officer), WMT 0.6% (Wal-Mart Mexico's same store sales rise 5.4% in March, according to reports), SBUX 0.7% (plans to add 100 new stores in Indonesia over three years and 100 new stores in the Philippines over the next four years) Analyst related: Upgrades: EAT 2% (upgraded to Buy from Neutral at Goldman), ULTA 1.2% (upgraded to Buy from Hold at Jefferies)... Misc: COH 0.4% (Hearing cautious comments at UBS citing negative datapoints on discount pricing ), JACK 1.2% (Hearing positive mention at BofA/Merrill, sees significant operating EPS growth ), PNRA 3% (added to Conviction Buy list at Goldman), DPZ 1.2% (removed from Conviction Buy list at Goldman), CASY 0% (initiated with a Market Perform at Wells Fargo), SUSS 2% and PTRY 2.4% (initiated with an Outperform at Wells Fargo), LNKD 1.1% (tgt raised to $210 from $180 at Morgan Stanley)
Leaders: SKT 0.6% (increases quarterly dividend by 7.1% to $0.225 per share from $0.21 per share), CVS 1.7% (CVS Caremark to pay $11 mln in drug-record settlement, according to reports), CROX 0.8% (Crocs named Andy Sackmann as chief marketing officer), WMT 0.6% (Wal-Mart Mexico's same store sales rise 5.4% in March, according to reports), SBUX 0.7% (plans to add 100 new stores in Indonesia over three years and 100 new stores in the Philippines over the next four years) Analyst related: Upgrades: EAT 2% (upgraded to Buy from Neutral at Goldman), ULTA 1.2% (upgraded to Buy from Hold at Jefferies)... Misc: COH 0.4% (Hearing cautious comments at UBS citing negative datapoints on discount pricing ), JACK 1.2% (Hearing positive mention at BofA/Merrill, sees significant operating EPS growth ), PNRA 3% (added to Conviction Buy list at Goldman), DPZ 1.2% (removed from Conviction Buy list at Goldman), CASY 0% (initiated with a Market Perform at Wells Fargo), SUSS 2% and PTRY 2.4% (initiated with an Outperform at Wells Fargo), LNKD 1.1% (tgt raised to $210 from $180 at Morgan Stanley)
